Thymoma associated with autoimmune diseases: 85 cases and literature review

Autoimmunity Reviews

Volumn 15, Issue 1, 2016, Pages 82-92

  Bernard, C ^a   Frih, H ^a   Pasquet, F ^b   Kerever, S ^c,d,e   Jamilloux, Y ^a   Tronc, F ^f   Guibert, B ^g   Isaac, S ^g   Devouassoux, M ^a   Chalabreysse, L ^f   Broussolle, C ^a   Petiot, P ^a   Girard, N ^f   Seve P ^a  

^a UNIVERSITÉ LYON 1   (France)

^b Desgenettes Army Training Hospital   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

^d INSERM   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f LOUIS PRADEL HOSPITAL   (France)

^g CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Autoimmune disease; Isaac's syndrome; Morvan syndrome; Myasthenia gravis; Thymectomy; Thymoma

Indexed keywords

ADULT; APLASTIC ANEMIA; AUTOIMMUNE DISEASE; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOIMMUNE HEPATITIS; AUTOIMMUNE THYROIDITIS; CANCER DIAGNOSIS; CANCER SURGERY; CLINICAL FEATURE; CYTOPENIA; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GOOD SYNDROME; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; ISAAC SYNDROME; LICHEN PLANUS; MAJOR CLINICAL STUDY; MALE; MORVAN SYNDROME; MYASTHENIA GRAVIS; MYOSITIS; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PARANEOPLASTIC NEUROPATHY; PARANEOPLASTIC PEMPHIGUS; PEMPHIGUS; POLYMYOSITIS; PURE RED CELL ANEMIA; RETROSPECTIVE STUDY; REVIEW; SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; THYMECTOMY; THYMOMA; AUTOIMMUNITY; RISK FACTOR; THYMUS NEOPLASMS;

AUTOIMMUNITY; HUMANS; RISK FACTORS; THYMECTOMY; THYMOMA; THYMUS NEOPLASMS;

EID: 84955216438     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2015.09.005     Document Type: Review

References (171)

1. Miller J.F.A.P. Revisiting thymus function. Front Immunol 2014, 5:411.
2. Klein L., Kyewski B., Allen P.M., Hogquist K.A. Positive and negative selection of the T cell repertoire: what thymocytes see (and don't see). Nat Rev Immunol 2014, 14:377-391.
3. Kondo K., Yoshizawa K., Tsuyuguchi M., Kimura S., Sumitomo M., Morita J., et al. WHO histologic classification is a prognostic indicator in thymoma. Ann Thorac Surg 2004, 77:1183-1188.
4. Hoffacker V., Schultz A., Tiesinga J.J., Gold R., Schalke B., Nix W., et al. Thymomas alter the T-cell subset composition in the blood: a potential mechanism for thymoma-associated autoimmune disease. Blood 2000, 96:3872-3879.
5. Souadjian J.V., Enriquez P., Silverstein M.N., Pépin J.M. The spectrum of diseases associated with thymoma. Coincidence or syndrome?. Arch Intern Med 1974, 134:374-379.
6. Fujii Y. Thymus, thymoma and myasthenia gravis. Surg Today 2013, 43:461-466.
7. Ashour M.H., Jain S.K., Kattan K.M., al-Daeef A.Q., Abdal Jabbar M.S., al-Tahan A.R., et al. Maximal thymectomy for myasthenia gravis. Eur J Cardiovasc Thorac Surg 1995, 9:461-464.
8. Lindstrom J., Shelton D., Fujii Y. Myasthenia gravis. Adv Immunol 1988, 42:233-284.
9. Soltys J., Gong B., Kaminski H.J., Zhou Y., Kusner L.L. Extraocular muscle susceptibility to myasthenia gravis: unique immunological environment?. Ann N Y Acad Sci 2008, 1132:220-224.
10. Perlo V.P., Arnason B., Poskanzer D., Castleman B., Schwab R.S., Osserman K.E., et al. The role of thymectomy in the treatment of myasthenia gravis. Ann N Y Acad Sci 1971, 183:308-315.
11. Emeryk B., Strugalska M.H. Evaluation of results of thymectomy in myasthenia gravis. J Neurol 1976, 211:155-168.
12. Shelly S., Agmon-Levin N., Altman A., Shoenfeld Y. Thymoma and autoimmunity. Cell Mol Immunol 2011, 8:199-202.
13. Levy Y., Afek A., Sherer Y., Bar-Dayan Y., Shibi R., Kopolovic J., et al. Malignant thymoma associated with autoimmune diseases: a retrospective study and review of the literature. Semin Arthritis Rheum 1998, 28:73-79.
14. Boonen A., Rennenberg R., van der Linden S. Thymoma-associated systemic lupus erythematosus, exacerbating after thymectomy. A case report and review of the literature. Rheumatology (Oxford) 2000, 39:1044-1046.
15. D'Andrea V., Malinovsky L., Ambrogi V., Artico M., Capuano L.G., Buccolini F., et al. Thymectomy as treatment of autoimmune diseases other than myasthenia gravis. Thymus 1993, 21:1-10.
16. Masaoka A. Staging system of thymoma. J Thorac Oncol 2010, 5:S304-S312.
17. Osserman K.E., Genkins G. Critical reappraisal of the use of edrophonium (tensilon) chloride tests in myasthenia gravis and significance of clinical classification. Ann N Y Acad Sci 1966, 135:312-334.
18. Osserman K.E., Genkins G. Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients. Mt Sinai J Med N Y 1971, 38:497-537.
19. Filosso P.L., Venuta F., Oliaro A., Ruffini E., Rendina E.A., Margaritora S., et al. Thymoma and inter-relationships between clinical variables: a multicentre study in 537 patients. Eur J Cardiovasc Thorac Surg 2014, 45:1020-1027.
20. Filosso P.L., Guerrera F., Evangelista A., Welter S., Thomas P., Casado P.M., et al. Prognostic model of survival for typical bronchial carcinoid tumours: analysis of 1109 patients on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine Tumours Working Group†. Eur J Cardiovasc Thorac Surg 2015, 48:441-447.
21. Holbro A., Jauch A., Lardinois D., Tzankov A., Dirnhofer S., Hess C. High prevalence of infections and autoimmunity in patients with thymoma. Hum Immunol 2012, 73:287-290.
22. Le Péchoux C., Mahé M., Bretel J.-J., Roberti E., Ruffié P. Thymic tumors. Cancer Radiother J Soc Fr Radiother Oncol 2005, 9:351-357.
23. Citterio A., Beghi E., Millul A., Evoli A., Mantegazza R., Antozzi C., et al. Risk factors for tumor occurrence in patients with myasthenia gravis. J Neurol 2009, 256:1221-1227.
24. Evoli A., Minicuci G.M., Vitaliani R., Battaglia A., Della Marca G., Lauriola L., et al. Paraneoplastic diseases associated with thymoma. J Neurol 2007, 254:756-762.
25. Kelesidis T., Yang O. Good's syndrome remains a mystery after 55years: a systematic review of the scientific evidence. Clin Immunol (Orlando) 2010, 135:347-363.
26. Liu Y., Zhang H., Zhang P., Meng F., Chen Y., Wang Y., et al. Autoimmune regulator expression in thymomas with or without autoimmune disease. Immunol Lett 2014, 161:50-56.
27. Chen X, Fang L, Song S, Guo TB, Liu A, Zhang JZ. Thymic regulation of autoimmune disease by accelerated differentiation of Foxp3+ regulatory T cells through IL-7 signaling pathway. J Immunol Baltim Md 1950 2009;183:6135-44.
28. Sherer Y., Bardayan Y., Shoenfeld Y. Thymoma, thymic hyperplasia, thymectomy and autoimmune diseases (review). Int J Oncol 1997, 10:939-943.
29. Okumura M., Fujii Y., Shiono H., Inoue M., Minami M., Utsumi T., et al. Immunological function of thymoma and pathogenesis of paraneoplastic myasthenia gravis. Gen Thorac Cardiovasc Surg 2008, 56:143-150.
30. Kyewski B.A. Thymic dendritic cells present blood-borne antigens to medullary thymocytes in vivo: a possible role in the generation of the T-cell repertoire. Haematol Blood Transfus 1985, 29:486-491.
31. Zuklys S, Balciunaite G, Agarwal A, Fasler-Kan E, Palmer E, Holländer GA. Normal thymic architecture and negative selection are associated with Aire expression, the gene defective in the autoimmune-polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). J Immunol Baltim Md 1950 2000;165:1976-83.
32. Puissant B. Thymus function and autoimmunity. Rev Med Interne Fondée Par Soc Natl Fr Med Interne 2004, 25:562-572.
33. Marx A., Pfister F., Schalke B., Saruhan-Direskeneli G., Melms A., Ströbel P. The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes. Autoimmun Rev 2013, 12:875-884.
34. Grob D., Brunner N., Namba T., Pagala M. Lifetime course of myasthenia gravis. Muscle Nerve 2008, 37:141-149.
35. Tormoehlen L.M., Pascuzzi R.M. Thymoma, myasthenia gravis, and other paraneoplastic syndromes. Hematol Oncol Clin North Am 2008, 22:509-526.
36. Ramanujam R., Piehl F., Pirskanen R., Gregersen P.K., Hammarström L. Concomitant autoimmunity in myasthenia gravis-lack of association with IgA deficiency. J Neuroimmunol 2011, 236:118-122.
37. Mao Z.-F., Yang L.-X., Mo X.-A., Qin C., Lai Y.-R., He N.-Y., et al. Frequency of autoimmune diseases in myasthenia gravis: a systematic review. Int J Neurosci 2011, 121:121-129.
38. Jallouli M., Saadoun D., Eymard B., Leroux G., Haroche J., Le Thi Huong D., et al. The association of systemic lupus erythematosus and myasthenia gravis: a series of 17 cases, with a special focus on hydroxychloroquine use and a review of the literature. J Neurol 2012, 259:1290-1297.
39. Sardu C., Cocco E., Mereu A., Massa R., Cuccu A., Marrosu M.G., et al. Population based study of 12 autoimmune diseases in Sardinia, Italy: prevalence and comorbidity. PLoS One 2012, 7.
40. Rosenow E.C., Hurley B.T. Disorders of the thymus. A Review. Arch Intern Med 1984, 144:763-770.
41. Bouhour F., Confavreux C. Myasthenia. Rev Prat 2005, 55:1927-1932.
42. Marx A., Willcox N., Leite M.I., Chuang W.-Y., Schalke B., Nix W., et al. Thymoma and paraneoplastic myasthenia gravis. Autoimmunity 2010, 43:413-427.
43. Zisimopoulou P., Brenner T., Trakas N., Tzartos S.J. Serological diagnostics in myasthenia gravis based on novel assays and recently identified antigens. Autoimmun Rev 2013, 12:924-930.
44. Alkhawajah N.M., Oger J. Late-onset myasthenia gravis: a review when incidence in older adults keeps increasing. Muscle Nerve 2013, 48:705-710.
45. Gronseth G.S., Barohn R.J. Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000, 55:7-15.
46. Genty I., Jean R., Cretel E., Xeridat B., Astoul P., Poulain P., et al. Thymoma and disseminated lupus erythematosus. Two new cases and review of the literature. Rev Med Interne Fondée Par Soc Natl Fr Med Interne 2001, 22:475-484.
47. Zhang L., Dong J., Leng X.-M., Zeng X.-F. A meta-analysis of thymoma-associated systemic lupus erythematosus from 1975-2008 worldwide. Zhonghua Nei Ke Za Zhi 2009, 48:643-646.
48. Cervera R. Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project.". Autoimmun Rev 2006, 5:180-186.
49. Agus B., Kristt D., Gumport S.L., Sunshine A. Thymoma associated with metastatic skin cancer and systemic lupus erythematosus. N Y State J Med 1975, 75:1538-1541.
50. Bozzolo E., Bellone M., Quaroni N., Voci C., Sabbadini M.G. Thymoma associated with systemic lupus erythematosus and immunologic abnormalities. Lupus 2000, 9:151-154.
51. Calabrese L.H., Bach J.F., Currie T., Vidt D., Clough J., Krakauer R.S. Development of systemic lupus erythematosus after thymectomy for myasthenia gravis. Studies of suppressor cell function. Arch Intern Med 1981, 141:253-255.
52. Claudy A.L., Touraine J.L., Schmitt D., Viac J., Moreau X. Thymoma and lupus erythematosus. Report of 3 cases. Thymus 1983, 5:209-222.
53. Cruz P.D., Coldiron B.M., Sontheimer R.D. Concurrent features of cutaneous lupus erythematosus and pemphigus erythematosus following myasthenia gravis and thymoma. J Am Acad Dermatol 1987, 16:472-480.
54. Duchmann R., Schwarting A., Poralla T., Meyer zum Büschenfelde KH, Hermann E, Thymoma and pure red cell aplasia in a patient with systemic lupus erythematosus. Scand J Rheumatol 1995, 24:251-254.
55. Fournel P., Emonot A., Claudy A.L., Boucheron S., Baril A. Thymoma and lupus: apropos of a case with recurrences and histological dedifferentiation. Rev Pneumol Clin 1987, 43:98-101.
56. Jang S.-J., Wu Y.-C., Chuang W.-Y., Chung C.-M., Luo S.-F., Chu P.-H. Impending cardiac tamponade as the initial presentation of thymoma in a systemic lupus erythematosus patient. Lupus 2010, 19:337-340.
57. Karras A., de Montpreville V., Fakhouri F., Grünfeld J.-P., Lesavre P., Groupe d'Etudes des Néphropathies Associées aux Thymomes Renal and thymic pathology in thymoma-associated nephropathy: report of 21 cases and review of the literature. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc Eur Ren Assoc 2005, 20:1075-1082.
58. Larsson O. Thymoma and systemic lupus erythematosus in the same patient. Lancet 1963, 2:665-666.
59. MacKechnie H.L., Squires A.H., Platts M., Pruzanski W. Thymoma, myasthenia gravis, erythroblastopenic anemia and systemic lupus erythematosus in one patient. Can Med Assoc J 1973, 109:733-738.
60. Malas D., Weiss S. Progressive multifocal leukoencephalopathy and cryptococcal meningitis with systemic lupus erythematosus and thymoma. Ann Neurol 1977, 1:188-191.
61. Mastaglia F.L., Papadimitriou J.M., Dawkins R.L., Beveridge B. Vacuolar myopathy associated with chloroquine, lupus erythematosus and thymoma: report of a case with unusual mitochondrial changes and lipid accumulation in muscle. J Neurol Sci 1977, 34:315-328.
62. Menon S., Snaith M.L., Isenberg D.A. The association of malignancy with SLE: an analysis of 150 patients under long-term review. Lupus 1993, 2:177-181.
63. Mevorach D., Perrot S., Buchanan N.M., Khamashta M., Laoussadi S., Hughes G.R., et al. Appearance of systemic lupus erythematosus after thymectomy: four case reports and review of the literature. Lupus 1995, 4:33-37.
64. Mizon J.P., Morcamp D., Lefebvre P., Froissart M., Guidicelli C.P., Goasguen J. Associated myasthenia and disseminated lupus erythematosus. A report on two cases and complete review of the published literature (author's transl). Ann Med Interne 1979, 130:489-500.
65. Ng Ng, Chng, Pemphigus foliaceus and oral lichen planus in a patient with systemic lupus erythematosus and thymoma. Clin Exp Dermatol 1998, 23:181-184.
66. O'Sullivan S.S., Mullins G.M., Neligan A., McNamara B., Galvin R.J. Acquired generalised neuromyotonia, cutaneous lupus erythematosus and alopecia areata in a patient with myasthenia gravis. Clin Neurol Neurosurg 2007, 109:374-375.
67. Ogawa M., Ueda S., Ohto M., Baba M., Yamaguchi Y., Kondo Y., et al. Development of systemic lupus erythematosus after total resection of a thymoma and the adjacent thymic gland. J Rheumatol 1992, 19:1130-1132.
68. Rosman A., Atsumi T., Khamashta M.A., Ames P.R., Hughes G.R. Development of systemic lupus erythematosus after chemotherapy and radiotherapy for malignant thymoma. Br J Rheumatol 1995, 34:1175-1176.
69. Steven M.M., Westedt M.L., Eulderink F., Hazevoet H.M., Dijkman J.H., Cats A. Systemic lupus erythematosus and invasive thymoma: report of two cases. Ann Rheum Dis 1984, 43:825-828.
70. Imamura S., Takigawa M., Ikai K., Yoshinaga H., Yamada M. Pemphigus foliaceus, myasthenia gravis, thymoma and red cell aplasia. A case report and indirect immunofluorescence study on 38 patients with myasthenia gravis. Clin Exp Dermatol 1978, 3:285-291.
71. Zandman-Goddard G., Lorber M., Shoenfeld Y. Systemic lupus erythematosus and thymoma-a double-edged sword. Int Arch Allergy Immunol 1995, 108:99-102.
72. Charles R.J., Sabo K.M., Kidd P.G., Abkowitz J.L. The pathophysiology of pure red cell aplasia: implications for therapy. Blood 1996, 87:4831-4838.
73. Thompson C.A., Steensma D.P. Pure red cell aplasia associated with thymoma: clinical insights from a 50-year single-institution experience. Br J Haematol 2006, 135:405-407.
74. Ketata W., Fouzi S., Msaad S., Ben Amira S., Yangui I., Ayoub A. Thymoma associated with pure red cell aplasia and Kaposi's sarcoma. Rev Mal Respir 2009, 26:78-82.
75. Hirokawa M., Sawada K., Fujishima N., Nakao S., Urabe A., Dan K., et al. Long-term response and outcome following immunosuppressive therapy in thymoma-associated pure red cell aplasia: a nationwide cohort study in Japan by the PRCA collaborative study group. Haematologica 2008, 93:27-33.
76. Levasseur P., Menestrier M., Gaud C., Dartevelle P., Julia P., Rojas-Miranda A., et al. Thymomas and associated diseases. Apropos of a series of 255 surgically treated thymomas. Rev Mal Respir 1988, 5:173-178.
77. Lewis J.E., Wick M.R., Scheithauer B.W., Bernatz P.E., Taylor W.F. Thymoma. A clinicopathologic review. Cancer 1987, 60:2727-2743.
78. De Castro M.A., de Castro M.A., de Arantes A., M, Roberti M do RF, Thymoma followed by aplastic anemia - two different responses to immunosuppressive therapy. Rev Bras Hematol Hemoter 2011, 33:476-477.
79. Bajel A., Ryan A., Roy S., Opat S.S. Aplastic anaemia: autoimmune sequel of thymoma. Br J Haematol 2009, 147:591.
80. Ritchie D.S., Underhill C., Grigg A.P. Aplastic anemia as a late complication of thymoma in remission. Eur J Haematol 2002, 68:389-391.
81. Park C.Y., Kim H.J., Kim Y.J., Park Y.H., Lee J.W., Min W.S., et al. Very severe aplastic anemia appearing after thymectomy. Korean J Intern Med 2003, 18:61-63.
82. Dinçol G., Saka B., Aktan M., Nalçaci M., Keskin H., Palanduz S., et al. Very severe aplastic anemia following resection of lymphocytic thymoma: effectiveness of antilymphocyte globulin, cyclosporin A, and granulocyte-colony stimulating factor. Am J Hematol 2000, 64:78-79.
83. Talerman A., Amigo A. Thymoma associated with aregenerative and aplastic anemia in a five-year-old child. Cancer 1968, 21:1212-1218.
84. Kobayashi H., Kitano K., Ishida F., Saito H., Miyabayashi H., Yonezawa T., et al. Aplastic anemia and idiopathic thrombocytopenic purpura with antibody to platelet glycoprotein IIb/IIIa following resection of malignant thymoma. Acta Haematol 1993, 90:42-45.
85. Liozon E., Touati M., Allegraud A., Gachard N., Loustaud V., Vidal E., et al. Thymoma-associated pancytopenia: effectiveness of cyclosporine A. Ann Hematol 1998, 77:175-178.
86. Mamiya S., Itoh T., Miura A.B. Acquired pure red cell aplasia in Japan. Eur J Haematol 1997, 59:199-205.
87. Koizumi K., Nakao S., Haseyama Y., Kato H., Ohi M., Motohara T., et al. Severe aplastic anemia associated with thymic carcinoma and partial recovery of hematopoiesis after thymectomy. Ann Hematol 2003, 82:367-370.
88. Bacigalupo A. Aplastic anemia: pathogenesis and treatment. Hematol Educ Program Am Soc Hematol Am Soc Hematol Educ Program 2007, 23-8. 10.1182/asheducation-2007.1.23.
89. Suzuki S., Utsugisawa K., Yoshikawa H., Motomura M., Matsubara S., Yokoyama K., et al. Autoimmune targets of heart and skeletal muscles in myasthenia gravis. Arch Neurol 2009, 66:1334-1338.
90. Tuncer Elmaci N., Ratip S., Ince-Günal D., Tanridağ T. Myasthenia gravis with thymoma and autoimmune haemolytic anaemia. A case report. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol 2003, 24:34-36.
91. Qin J., Liu L. Thymoma with idiopathic thrombocytopenic purpura: report of a case. J Thorac Cardiovasc Surg 2005, 129:453.
92. Matsuge S., Hosokawa Y., Murakami Y., Satoh K. Thymoma with idiopathic thrombocytopenic purpura preceded by mediastinal hemorrhage: report of a case. Kyobu Geka 2002, 55:899-902.
93. Mineo T.C., Biancari F., D'Andrea V. Myasthenia gravis, psychiatric disturbances, idiopathic thrombocytopenic purpura, and lichen planus associated with cervical thymoma. J Thorac Cardiovasc Surg 1996, 111:486-487.
94. Desai P.C., Jones P. Pure white cell aplasia in a patient with thymic carcinoma. Blood 2013, 122:1340.
95. Akinosoglou K., Melachrinou M., Siagris D., Koletsis E., Marangos M., Gogos C.A., et al. Good's syndrome and pure white cell aplasia complicated by cryptococcus infection: a case report and review of the literature. J Clin Immunol 2014, 34:283-288.
96. Ackland S.P., Bur M.E., Adler S.S., Robertson M., Baron J.M. White blood cell aplasia associated with thymoma. Am J Clin Pathol 1988, 89:260-263.
97. Hatama S., Kumagai H., Iwato K., Fujiwara M., Fujishima M. Thrombotic thrombocytopenic purpura accompanied by transient pure red cell aplasia and thymoma. Clin Nephrol 1998, 49:193-197.
98. Gay C.M., William W.N., Wang S.A., Oo T.H. Thymoma complicated by acquired amegakaryocytic thrombocytopenia and pure red cell aplasia. J Natl Compr Canc Netw 2014, 12:1505-1509.
99. Maslovsky I., Gefel D., Uriev L., Ben Dor D., Lugassy G. Malignant thymoma complicated by amegakaryocytic thrombocytopenic purpura. Eur J Intern Med 2005, 16:523-524.
100. Ueda K., Matsubara A., Kizuki N., Sato Y., Oka Y., Hosaka T. Successful treatment of acquired pure red cell aplasia and acquired amegakaryocytic thrombocytopenia with anti-thymocyte globulin. Am J Hematol 2001, 66:154-155.
101. Cho A.R., Cha Y.J., Kim H.R., Park E.K., Cha E.J. Acquired amegakaryocytic thrombocytopenia after thymectomy in a case of pure red cell aplasia associated with thymoma. Korean J Lab Med 2010, 30:244-248.
102. Sato K., Nojiri S., Numata T., Kinoshita A., Sakaguchi S., Homma S. Case of agranulocytosis associated with thymoma. Nihon Kokyūki Gakkai Zasshi J Jpn Respir Soc 2008, 46:101-105.
103. Jethava Y., Alamelu J., Rangarajan S., Lang-Lazdunski L., van der Walt J., Fields P. Acquired agranulocytosis and factor XI deficiency in association with thymoma. J Clin Oncol Off J Am Soc Clin Oncol 2011, 29:e604-e606.
104. Castleman B., McNeely B.U. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 40-1971. N Engl J Med 1971, 285:847-855.
105. Humbert P, Dupond JL, Mallet H, Leconte des Floris R. Biermer's anemia, Hashimoto's thyroiditis, myasthenia and malignant thymoma. HLA B8, DR3, and DR5 antigens. Presse Médicale Paris Fr 1983 1984;13:439.
106. Davila D.G., Ryan D.H. Thymoma, hypogammaglobulinemia, and pernicious anemia. South Med J 1986, 79:904-906.
107. Soppi E., Eskola J., Röyttä M., Veromaa T., Panelius M., Lehtonen A. Thymoma with immunodeficiency (Good's syndrome) associated with myasthenia gravis and benign IgG gammopathy. Arch Intern Med 1985, 145:1704-1707.
108. Hashizume T. Good's syndrome and pernicious anemia. Intern Med Tokyo Jpn 2002, 41:1062-1064.
109. Robins-Browne R.M., Green R., Katz J., Becker D. Thymoma, pure red cell aplasia, pernicious anaemia and candidiasis: a defect in immunohomeostasis. Br J Haematol 1977, 36:5-13.
110. Ahmed A., Simmons Z. Isaacs syndrome: a review. Muscle Nerve 2015, 52(1):5-12.
111. Hart I.K., Maddison P., Newsom-Davis J., Vincent A., Mills K.R. Phenotypic variants of autoimmune peripheral nerve hyperexcitability. Brain J Neurol 2002, 125:1887-1895.
112. Vernino S., Lennon V.A. Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability. Muscle Nerve 2002, 26:702-707.
113. Irani S.R., Alexander S., Waters P., Kleopa K.A., Pettingill P., Zuliani L., et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain J Neurol 2010, 133:2734-2748.
114. Vincent A., Irani S.R. Caspr2 antibodies in patients with thymomas. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer 2010, 5:S277-S280.
115. Skeie G.O., Apostolski S., Evoli A., Gilhus N.E., Illa I., Harms L., et al. Guidelines for treatment of autoimmune neuromuscular transmission disorders. Eur J Neurol Off J Eur Fed Neurol Soc 2010, 17:893-902.
116. Maddison P. Neuromyotonia. Clin Neurophysiol Off J Int Fed Clin Neurophysiol 2006, 117:2118-2127.
117. Rana S.S., Ramanathan R.S., Small G., Adamovich B. Paraneoplastic Isaacs' syndrome: a case series and review of the literature. J Clin Neuromuscul Dis 2012, 13:228-233.
118. Fleisher J., Richie M., Price R., Scherer S., Dalmau J., Lancaster E. Acquired neuromyotonia heralding recurrent thymoma in myasthenia gravis. JAMA Neurol 2013, 70:1311-1314.
119. Josephs K.A., Silber M.H., Fealey R.D., Nippoldt T.B., Auger R.G., Vernino S. Neurophysiologic studies in Morvan syndrome. J Clin Neurophysiol Off Publ Am Electroencephalogr Soc 2004, 21:440-445.
120. Irani S.R., Pettingill P., Kleopa K.A., Schiza N., Waters P., Mazia C., et al. Morvan syndrome: clinical and serological observations in 29 cases. Ann Neurol 2012, 72:241-255.
121. Ong E., Viaccoz A., Ducray F., Pérol M., Cavillon G., Rogemond V., et al. Dramatic improvement after rituximab in a patient with paraneoplastic treatment-refractory Morvan syndrome associated with anti-CASPR2 antibodies. Eur J Neurol 2013, 20:e96-e97.
122. Graus F., Dalmau J. CNS autoimmunity: new findings and pending issues. Lancet Neurol 2012, 11:17-19.
123. Simabukuro M.M., Petit-Pedrol M., Castro L.H., Nitrini R., Lucato L., Zambon A.A., et al. GABAA receptor and LGI1 antibody encephalitis in a patient with thymoma. Neurol Neuroimmunol Neuroinflammation 2015, 2.
124. Petit-Pedrol M., Armangue T., Peng X., Bataller L., Cellucci T., Davis R., et al. Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies. Lancet Neurol 2014, 13:276-286.
125. Lai M., Huijbers M.G.M., Lancaster E., Graus F., Bataller L., Balice-Gordon R., et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 2010, 9:776-785.
126. Vernino S., Lennon V.A. Autoantibody profiles and neurological correlations of thymoma. Clin Cancer Res 2004, 10:7270-7275.
127. Dalmau J., Lancaster E., Martinez-Hernandez E., Rosenfeld M.R., Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011, 10:63-74.
128. Skeie G.O., Romi F., Aarli J.A., Bentsen P.T., Gilhus N.E. Pathogenesis of myositis and myasthenia associated with titin and ryanodine receptor antibodies. Ann N Y Acad Sci 2003, 998:343-350.
129. Rini B.I., Gajewski T.F. Polymyositis with respiratory muscle weakness requiring mechanical ventilation in a patient with metastatic thymoma treated with octreotide. Ann Oncol 1999, 10:973-979.
130. Aarli J.A. Inflammatory myopathy in myasthenia gravis. Curr Opin Neurol 1998, 11:233-234.
131. Van de Warrenburg B.P.C., Hengstman G.J.D., Vos P.E., Boerman R.H., ter Laak H.J., van Engelen B.G.M. Concomitant dermatomyositis and myasthenia gravis presenting with respiratory insufficiency. Muscle Nerve 2002, 25:293-296.
132. Ago T., Nakamura M., Iwata I., Murai H., Okuma K., Tsuru T., et al. Dermatomyositis associated with invasive thymoma. Intern Med Tokyo Jpn 1999, 38:155-159.
133. Iacovelli R., Palazzo A., Conte D., Fabbri M.A., Vitolo D., Cortesi E. Dermatomyositis as first clinical appearance for a thymic epidermoid cell carcinoma. Acta Biomed Ateneo Parmense 2010, 81:68-71.
134. Herrmann D.N., Blaivas M., Wald J.J., Feldman E.L. Granulomatous myositis, primary biliary cirrhosis, pancytopenia, and thymoma. Muscle Nerve 2000, 23:1133-1136.
135. Kidher E.S., Briceno N., Taghi A., Chukwuemeka A. An interesting collection of paraneoplastic syndromes in a patient with a malignant thymoma. BMJ Case Rep 2012, 2012.
136. Clerinx K., Breban T., Schrooten M., Leite M.I., Vincent A., Verschakelen J., et al. Progressive encephalomyelitis with rigidity and myoclonus: resolution after thymectomy. Neurology 2011, 76:303-304.
137. Barua A., Gozzard P., Martin-Ucar A.E., Maddison P. Neuronal antibodies and paraneoplastic sensory neuropathy in thymoma. Interact Cardiovasc Thorac Surg 2012, 15:516-517.
138. Arend S.M., Dik H., van Dissel J.T. Good's syndrome: the association of thymoma and hypogammaglobulinemia. Clin Infect Dis 2001, 32:323-325.
139. Malphettes M., Gérard L., Galicier L., Boutboul D., Asli B., Szalat R., et al. Good syndrome: an adult onset immune deficiency remarkable for its high incidence of invasive infections and autoimmune complications. Clin Infect Dis 2015, 61(2). (civ269).
140. Granel B., Gayet S., Christides C., Serratrice J., Rey J., Disdier P., et al. Thymoma and hypogammaglobulinemia. Good's syndrome: apropos of a case and review of the literature. Rev Med Interne Fondée Par Soc Natl Fr Med Interne 1999, 20:347-349.
141. Lee A.B., Thurston R.S. Malignant thymoma and myasthenia gravis presenting as polymyositis: a case report. J La State Med Soc 2008, 160:286-288.
142. Yapali S., Oruc N., Ilgun S., Yilmaz F., Aksu K., Yilmaz M., et al. Acute presentation of autoimmune hepatitis in a patient with myasthenia gravis, thymoma, Hashimoto thyroiditis and connective tissue disorder. Hepatol Res 2012, 42:835-839.
143. Kanazawa M., Shimohata T., Tanaka K., Nishizawa M. Clinical features of patients with myasthenia gravis associated with autoimmune diseases. Eur J Neurol 2007, 14:1403-1404.
144. Téllez-Zenteno J.F., Cardenas G., Estañol B., Garcia-Ramos G., Weder-Cisneros N. Associated conditions in myasthenia gravis: response to thymectomy. Eur J Neurol 2004, 11:767-773.
145. Chen Y.-L., Yeh J.-H., Chiu H.-C. Clinical features of myasthenia gravis patients with autoimmune thyroid disease in Taiwan. Acta Neurol Scand 2013, 127:170-174.
146. Yeh H.-H., Tung Y.-W., Yang C.-C., Tung J.-N. Myasthenia gravis with thymoma and coexistent central hypothyroidism. J Chin Med Assoc 2009, 72:91-93.
147. Rajan A., Kotlyar D., Giaccone G. Acute autoimmune hepatitis, myositis, and myasthenic crisis in a patient with thymoma. J Thorac Oncol 2013, 8:e87-e88.
148. Ko K.F., Ho T., Chan K.W. Autoimmune chronic active hepatitis and polymyositis in a patient with myasthenia gravis and thymoma. J Neurol Neurosurg Psychiatry 1995, 59:558-559.
149. Han Y.S., Kim B.H., Kim T.H., Dong S.H., Kim H.J., Chang Y.W., et al. Autoimmune hepatitis in a patient with myasthenia gravis and thymoma-a report on the first case in Korea. Korean J Intern Med 2000, 15:151-155.
150. Asakawa H., Kashihara T., Fukuda H., Yamamoto M. A patient with thymoma and four different organ-specific autoimmune diseases. Neth J Med 2002, 60:292-295.
151. Aigner E., Strassburg C.P., Strasser M., Pohla-Gubo G., Dietze O., Hutter J., et al. Transient autoimmune hepatitis induced by a thymoma. Am J Gastroenterol 2009, 104:1332-1334.
152. Mejri N., Chabchoub I., Gargouri I., Belaid I., Ezairi F., Hmissa S., et al. Effect of chemotherapy on autoimmune hepatitis in thymoma: a case report and literature review. Cancer Biol Med 2013, 10:169-173.
153. Eryilmaz M.K., Mutlu H., Salim D.K., Musri F.Y., Tural D., Başsorgun I., et al. Ipilimumab may increase the severity of cutenaous toxicity related to radiotherapy. J Oncol Pharm Pract 2015, pii: 1078155215572930.
154. Gibson L.E., Muller S.A. Dermatologic disorders in patients with thymoma. Acta Derm Venereol 1987, 67:351-356.
155. Choi Y., Nam K.-H., Lee J.-B., Lee J.Y., Ihm C.-W., Lee S.E., et al. Retrospective analysis of 12 Korean patients with paraneoplastic pemphigus. J Dermatol 2012, 39:973-981.
156. Ruocco E., Wolf R., Ruocco V., Brunetti G., Romano F., Lo Schiavo A. Pemphigus: associations and management guidelines: facts and controversies. Clin Dermatol 2013, 31:382-390.
157. Anhalt G.J., Kim S.C., Stanley J.R., Korman N.J., Jabs D.A., Kory M., et al. Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 1990, 323:1729-1735.
158. Winkler D.T., Strnad P., Meier M.L., Roten S., Went P., Lyrer P., et al. Myasthenia gravis, paraneoplastic pemphigus and thymoma, a rare triade. J Neurol 2007, 254:1601-1603.
159. Lee S.E., Hashimoto T., Kim S.-C. No mucosal involvement in a patient with paraneoplastic pemphigus associated with thymoma and myasthenia gravis. Br J Dermatol 2008, 159:986-988.
160. Meyer S., Kroiss M., Landthaler M., Vogt T. Thymoma, myasthenia gravis, eruptions of pemphigus vulgaris and a favourable course of relapsing melanoma: an immunological puzzle. Br J Dermatol 2006, 155:638-640.
161. Wang J., Bu D.F., Li T., Zheng R., Zhang B.X., Chen X.X., et al. Autoantibody production from a thymoma and a follicular dendritic cell sarcoma associated with paraneoplastic pemphigus. Br J Dermatol 2005, 153:558-564.
162. Barbetakis N., Samanidis G., Paliouras D., Chnaris A. eComment: paraneoplastic skin diseases in thymoma patients. Interact Cardiovasc Thorac Surg 2009, 9:346.
163. Takeshita K., Amano M., Shimizu T., Oyamada Y., Abiko T., Kobayashi K., et al. Thymoma with pemphigus foliaceus. Intern Med Tokyo Jpn 2000, 39:742-747.
164. Yoshida M., Miyoshi T., Sakiyama S., Kondo K., Tangoku A. Pemphigus with thymoma improved by thymectomy: report of a case. Surg Today 2013, 43:806-808.
165. Miyagaki T., Sugaya M., Miyamoto A., Nagata M., Ichimura Y., Mitsui H., et al. Oral erosive lichen planus associated with thymoma treated with etretinate. Australas J Dermatol 2013, 54:e25-e27.
166. Hayashi A., Shiono H., Okumura M. Thymoma accompanied by lichen planus. Interact Cardiovasc Thorac Surg 2008, 7:347-348.
167. Moutasim K.A., Poate T.W.J., Setterfield J.F., Challacombe S.J. A case of vulvovaginal gingival lichen planus in association with Good's syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008, 105:e57-e60.
168. Hahn J.M., Meisler D.M., Lowder C.Y., Tung R.C., Camisa C. Cicatrizing conjunctivitis associated with paraneoplastic lichen planus. Am J Ophthalmol 2000, 129:98-99.
169. Calista D. Oral erosive lichen planus associated with thymoma. Int J Dermatol 2001, 40:762-764.
170. Bobbio A., Vescovi P., Ampollini L., Rusca M. Oral erosive lichen planus regression after thymoma resection. Ann Thorac Surg 2007, 83:1197-1199.
171. Aronson I.K., Soltani K., Paik K.I., Rubenstein D., Lorincz A.L. Triad of lichen planus, myasthenia gravis, and thymoma. Arch Dermatol 1978, 114:255-258.